Werfen S.A., founded in 1966 and headquartered in Barcelona, Spain, specializes in in vitro diagnostics and is dedicated to advancing healthcare. The company offers a range of products and services including coagulometers, immunoassay analyzers, and data solutions for healthcare institutions and laboratories.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| WERFEN 0.50% 2026-10-28 EURWerfen S.A | Spain | 2026-10-28 | 0.500 | 2.70 |
| WERFEN 3.63% 2032-02-12 EURWerfen S.A | Spain | 2032-02-12 | 3.625 | 3.85 |
| WERFEN 4.25% 2030-05-03 EURWerfen S.A | Spain | 2030-05-03 | 4.250 | 3.59 |
| WERFEN 4.63% 2028-06-06 EURWerfen S.A | Spain | 2028-06-06 | 4.625 | 3.39 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Werfen has a history of strategic bond issuances that reflect its growth and adaptation in the healthcare sector. The company began issuing bonds in 2015 to support its expansion, with notable issuances including a €500 million bond in 2020 that offered a yield of 2.5%, which was competitive compared to industry averages. In 2023, Werfen announced plans for a new issuance linked to its acquisition strategy, illustrating its ongoing commitment to innovation while maintaining a solid investment profile.